Abstract Recent studies suggest that synaptic pathology in autism spectrum disorder (ASD) might be caused by the disruption of a signaling pathway at excitatory glutamatergic synapses, which can be influenced by environmental factors. Some factors, such as prenatal zinc deficiency, dysfunction of metallothioneins as well as deletion of COMMD1, all affect brain metal-ion homeostasis and have been associated with ASD. Given that COMMD1 regulates copper levels and that copper and zinc have antagonistic properties, here, we followed the idea that copper overload might induce a local zinc deficiency affecting key players of a putative ASD pathway such as ProSAP/Shank proteins as reported before. Our results show that increased copper levels indeed interfere with intracellular zinc concentrations and affect synaptic ProSAP/Shank levels, which similarly are altered by manipulation of copper and zinc levels through overexpression and knockdown of COM-MD1. In line with this, acute and prenatal copper overload lead to local zinc deficiencies in mice. Pups exposed to prenatal copper overload furthermore show a reduction in ProSAP/Shank protein levels in the brain as well as a decreased NMDAR subunit 1 concentration. Thus, it might be likely that brain metal ion status influences a distinct pathway in excitatory synapses associated with genetic forms of ASD.
Introduction
Metal ion homeostasis is essential for proper brain function and is implicated in severe neurological symptoms and cognitive diseases. For example, ASD can result from homozygous deletions of the MURR1/ COMMD1 gene, which is involved in the regulation of copper (Cu 2? ) homeostasis (Levy et al. 2011) . Complete loss of function of COMMD1 leads to an intracellular overload of Cu 2? , which reduces longterm potentiation (LTP) (Doreulee et al. 1997) . Cu 2? is usually stored in a non-toxic form within metallothioneins and excreted via a Cu 2? transport ATPase (ATP7B), which is implicated in another Cu 2? overloading disease, namely Wilson disease (Bost et al. 2012; Huster 2010) . The trafficking of ATP7B is regulated by COMMD1. ATP7B transfers Cu 2? to apoceruloplasmin, thus regulating the conversion of apoceruloplasmin to ceruloplasmin, which is further released into the blood stream and delivers Cu 2? towards the brain (Das and Ray 2006; de Bie et al. 2005) . Ceruloplasmin was already associated with ASD and the level of ceruloplasmin reduction correlates with the loss of previously acquired language skills in children with autism (Chauhan and Chauhan 2006) . The finding that the COMMD1 deletion results in an intracellular Cu 2? overload is particularly interesting, since former studies describe a significant elevation of Cu 2? in the hair and nail samples of subjects with ASD (Lakshmi Priya and Geetha 2011 ratio is increased in the blood serum of subjects with autism (Faber et al. 2009 ) and was suggested as biomarker for children with ASD. Within the body, Cu 2? and zinc (Zn 2? ) have competing roles in a way, where Cu 2? overload leads to Zn 2? deficiency (Hill and Matrone 1970; Mills 1985; Hall et al. 1979; Huster 2010) . Zn 2? deficiency similarly has been reported in many cases of autism (Grabrucker 2012) .
Recent studies have shown that Zn 2? is able to modulate synapses via ProSAP1/Shank2 and Pro-SAP2/Shank3 scaffold proteins (Baron et al. 2006; Grabrucker et al. 2011a ) at the postsynaptic density (PSD) of glutamatergic synapses (Grabrucker et al. 2011b) . Mutations associated with ASD have been reported in ProSAP1/Shank2, ProSAP2/Shank3, and Shank1 (Durand et al. 2007; Moessner et al. 2007; Gauthier et al. 2009; Berkel et al. 2010; Pinto et al. 2010; Sato et al. 2012) . Moreover, the loss of one copy of ProSAP2/Shank3 is the major cause of neurological symptoms seen in Phelan McDermid Syndrome, a disorder with autistic like behavior and epilepsy as major phenotype (Manning et al. 2004) . ProSAP/ Shank proteins not only bind trans-synaptic complexes of Neuroligins (Nlg) and Neurexins (Nrxn) (Meyer et al. 2004 ) thereby regulating presynaptic molecules like Piccolo via Nrxn/Nlg dependent trans-synaptic signaling (Arons et al. 2012 ), but also cluster receptors at the PSD such as group I mGluRs (Verpelli et al. 2011) , which are themselves influenced by fragile X mental retardation protein (FMRP) concentrations (Hagerman et al. 2010) . Mutations/deletions in those proteins have already been associated with ASD. Additionally, the malformation of ProSAP/Shank PSD platforms leads only to an impairment of excitatory synapse function, since ProSAP/Shank proteins cannot be found at inhibitory synapses (Naisbitt et al. 1999 ). This might lead to an imbalance of excitation and inhibition that may underlie several neurological diseases, such as ASD (Rubenstein and Merzenich 2003) .
Given that many of these ASD candidate genes can be placed in a common hypothetical pathway at excitatory glutamatergic synapses (Bourgeron 2009; Grabrucker et al. 2011b) , the deregulation of a critical member may represent a major genetic risk factor for ASD. The interplay of Cu 2? and Zn 2? might be a core regulatory component of this pathway disrupted in ASD (Grabrucker 2014) .
Here, we show that increased Cu 2? levels interfere with intracellular Zn 2? concentrations and possibly by that, affect synaptic ProSAP/Shank levels. Similarly, (Coyle et al. 1994) (Fig. 1a) . Interestingly, this increase is blocked by co-application of CuCl 2 and can only be slightly overcome by increased (20 lM) Zn 2? concentrations (Fig. 1a) . A similar effect could be observed in NIH cells (Fig. S1a) . Along with this, we investigated the extracellular Zn 2? and Cu 2? concentrations of cell cultures treated with 10 lM ZnCl 2 , 10 lM CuCl 2 or 10 lM ZnCl 2 and 10 lM CuCl 2 using atomic absorption spectrometry (AAS). The results show significantly increased levels of extracellular Zn 2? and Cu 2? after treatment with ZnCl 2 and CuCl 2 , respectively (Fig. 1b) . Application of ZnCl 2 together with CuCl 2 significantly impairs the uptake of Zn 2? leading to even higher extracellular Zn 2? levels. However, co-application of both trace metals also affects Cu 2? uptake (Fig. 1b) . To exclude toxic effects of ZnCl 2 and/or CuCl 2 , we quantified the number of cells per optic field. Our data show no significant increase in cell death nor could we detect significantly more swelling or pinching off of dendrites (Fig. S1b, c) .
The Zn 2? dependent up-regulation of ProSAP1/ Shank2 and ProSAP2/Shank3 similarly was inhibited by treatment of neurons with ZnCl 2 plus CuCl 2 , which was detected by a quantitative analysis of synaptic ProSAP1/Shank2 and Pro-SAP2/Shank3 immunofluorescence levels (Fig. 1c) . Analysis of the mean synaptic signal intensities of immunoreactive puncta of Shank1, which does not bind Zn 2? , as well as Homer1b/c, mGluR5 and Gephyrin, a scaffold protein of inhibitory synapses that do not contain ProSAP/Shank proteins show no general increase in PSD protein levels following ZnCl 2 and/or CuCl 2 supplementation (Fig. 1d) . However, synaptic immunofluorescence of mGluR5 receptors was elevated following Zn 2? -supplementation as reported before . In contrast, after supplementation of Zn 2? along with Cu 2? only a trend towards an increase remains, however no longer significant. The level of synaptic ProSAP1/Shank2 and ProSAP2/Shank3 was also reported increased after neuronal activity ). Stimulation of hippocampal neurons for 1 min using HiK ? (50 mM KCl) solution indeed increased the mean synaptic fluorescence intensity of ProSAP2/ Shank3 and less so ProSAP1/Shank2 puncta 1 h after treatment (Fig. 1e) . However, stimulation in presence of CuCl 2 impaired this activity dependent increase (Fig. 1e) . Given that ProSAP/Shank SAM domains have a low affinity for Cu 2? (Grabrucker et al. 2011a) levels can be seen in COMMD1 overexpressing cells, while levels in COMMD1 knock-down cells show a decrease. b Overexpression or knockdown of COMMD1 were achieved by transfection of GFP-COMMD1 and COMMD1 shRNA encoding plasmids, respectively, and a puncta by puncta analysis of fluorescence intensities of immunoreactive signals from 5 to 10 cells per group after 3 days of transfection was performed at DIV 14. For each cell, the ratio between the fluorescence intensity of the transfected cell (full arrows) and a neighboring untransfected cell (open arrows) was calculated. Additionally, cells were exposed to CuCl 2 and ZnCl 2 for 1 h. After treatment, synaptic ProSAP1/Shank2 and ProSAP2/ Shank3 levels in hippocampal neurons show a trend towards an increase in GFP-COMMD1 expressing cells and a decrease in COMMD1 knockdown cells. The values are shown in percent normalized to the respective controls (GFP expression (GFP Ctrl) and scrambled (scr) shRNA (scr-shRNA Ctrl)). c Comparing synaptic ProSAP1/Shank2 and ProSAP2/Shank3 levels in transfected cells with and without application of CuCl 2 and ZnCl 2 reveals a significant difference between COMMD1 overexpressing and knockdown cells. d Knockdown of COM-MD1 by transfection of a COMMD1 shRNA encoding plasmid does not significantly alter synaptic mGluR5 or Bassoon levels in hippocampal neurons with and without treatment with CuCl 2 and ZnCl 2 (left panel). Comparing mGluR5 or Bassoon levels in transfected cells before and after application of CuCl 2 and ZnCl 2 also reveals no significant alteration (right panel) Fig. 3 Copper-overload affects zinc homeostasis in pups of mice with increased copper-levels: a Brain region specific analysis of Zn 2? (using Zinpyr-1) using at least three optic field of view per brain region from three different animals shows a significant reduction in Zinpyr-1 staining correlating with Zn 2? concentrations in cortex and the average across all analyzed brain regions in pups from mice on a Cu 2? supplemented diet. b A brain region specific analysis of Zn 2? (using Timm staining) from different brain regions from three different pups per group shows a significant reduction of staining intensity in the hippcampus and averaged across hippocampus and cortex. Right panel Exemplary images of Timm staining for pups PD3 from wildtype and mice on a Cu 2? enriched diet. Signal intensity is shown also in color code. c Using qRT-PCR, whole brain mRNA levels were analyzed in three independent experiments from three pups of control and three pups of Cu 2? supplemented mice. mRNA expression levels were normalized against HMBS. Values are shown compared to controls (set to 100 %). A significant change in the expression level of metallothionein 1 (MT-1) can be observed together with a trend towards a decrease in MT-2 and MT-3. No significant alterations on mRNA level of the three ProSAP/Shank family members were detected. d Analysis of cell density by DAPI staining of nuclei in the two brain regions (Hippocampus and Cortex) of pups from control mice and mice on a Cu 2? enriched diet. At least three optic fields (red boxes) from three sections each of three animals per group were measured. No significant differences were detected GFP, GFP-COMMD1, scrambled (scr) shRNA, and COMMD1-shRNA (Fig S2a-d ) plasmids for 3 days and supplemented with ZnCl 2 and CuCl 2 for 1 h and the ratios of intracellular Zinquin fluorescence between transfected and untransfected neighboring cells calculated (Fig. 2a) . A significant increase in intracellular Zn 2? levels can be seen in COMMD1 overexpressing cells, while levels in COMMD1 knock-down cells show a decrease. Although these alterations did not lead to changes in synaptic ProSAP1/Shank2 and ProSAP2/Shank3 level assessed by immunofluorescence-quantification (Fig. S2d) , exposure of cells with altered COMMD1 levels to ZnCl 2 and CuCl 2 leads to an increase of ProSAP1/ Shank2 and ProSAP2/Shank3 concentrations in COM-MD1 overexpressing cells and to a reduction in COMMD1 knockdown cells, both seen as a trend (Fig. 2b) . Comparing the fluorescence intensities of cells with high and low COMMD1 levels between treated and untreated conditions, a significant change of synaptic ProSAP1/Shank2 and ProSAP2/Shank3 protein levels can be seen dependent on the COMMD1 expression level (Fig. 2c) . This influence of COM-MD1 was not observed for other synaptic proteins such as mGluR5 and Bassoon, where we could not detect significant alterations (Fig. 2d) . Given that COMMD1 is expressed in the CNS during development and in adult mice (Fig. S2e) overload on ProSAP/Shank scaffold formation in vivo by inducing brain Cu 2? overload in mice. To this end, mice were fed a Cu 2? enriched diet for 5 weeks. Adult treated mice did not show significant differences in body weight (Fig. S3a, b) or displayed signs of diseases. However, after 5 weeks of Cu 2? enriched diet, mice displayed hind limb clasping. The brain weight was significantly reduced and body/brain weight ratio significantly increased after 5 weeks of treatment compared to control mice fed a normal diet (Fig. S3c) . In line with this, the analysis of cell density revealed a clear trend towards a decrease in Cortex of Cu 2? supplemented mice using DAPI staining. To verify this finding, we performed Nissl staining and analyzed the cell density within a defined optic field across multiple brain sections. The results show a significant reduction in cell density in cortical regions while no reduction was visible in the hippocampus (Fig. S3d, e) S4c) .
We detected a significant decrease in total brain Zn 2? content using ICP-MS (Fig. S4d, e) . To further investigate this Zn 2? deficiency in more detail, we labeled Zn 2? ions using Zinypr-1, a Zn 2? sensitive fluorescent probe (Fig. S4f) , in mouse brain sections. A brain region specific analysis reveals a significant decrease of Zn 2? in the hippocampus and a trend towards a decrease in cortex (Fig. S4g) . Using Timm's staining, we similarly detected a significant decrease of Zn 2? in the hippocampus (Fig. S4h) . Based on these results, we conclude that alterations in body Cu 2? levels lead to a Zn 2? deficiency within the CNS that is more pronounced in brain regions rich in Zn 2? such as the hippocampus.
Pups of copper supplemented mothers show reduced brain zinc levels Next, we investigated whether the Cu 2? enriched diet of the mother altered brain Zn 2? content of pups using Timm staining and a metal-ion specific fluorophore (Fig. 3a, b) . We labeled Zn 2? ions using Zinypr-1, a Zn 2? sensitive fluorescent probe (Fig. 3a) , in brain sections of control pups and pups from mice on a Cu 2? enriched diet. A brain region specific analysis reveals a significant decrease of Zn 2? in the cortex and a trend towards a decrease in hippocampus as well as a significant decrease of Zn 2? levels on average across all brain regions (Fig. 3a) . Using Timm's staining, we similarly could show a significant decrease of Zn 2? levels in average across all brain regions, however, here, the hippocampus shows a significant decrease while the cortex shows a trend (p = 0.083) (Fig. 3b) . The brains of pups from mice on a Cu 2? enriched diet did not show alterations in general brain morphology and the number of cells evaluated by DAPI staining in different brain regions was unchanged (Fig. 3d) .
Whole brain mRNA levels normalized against HMBS of pups from control and pups from Cu 2? supplemented mice were analyzed. In contrast to acute Cu 2? supplemented animals (Fig. S5a) , a significant change in the expression level of MT-1 was observed together with a trend towards a decrease in MT-2 and MT-3. No significant alterations on mRNA level of the three ProSAP/Shank family members were detected (Fig. 3c) .
Increased copper levels affect synaptic ProSAP/ Shank and GluN1 levels in vivo
To analyze, whether Cu 2? overload or the resulting Zn 2? deficiency alter protein expression levels at the synapse, in particular those of the ASD pathway associated proteins of the ProSAP/Shank family, we prepared P2 fractions from mothers treated with a Cu 2? supplemented diet and their pups and compared protein expression via Western Blot analysis to that of control animals. In contrast to mRNA levels, analyzing protein expression levels from whole brain P2 fractions of pups (PD3) from mice on a Cu 2? enriched diet, we found a significant decrease of ProSAP1/ Shank2, all three major isoforms of ProSAP2/Shank3, and COMMD1 normalized against Actin and compared to pups from control mice (Fig. 4a) . The levels of MT-1 are significantly increased. These alterations occurred specifically in pups since using whole brain lysate of Cu 2? supplemented mothers (Fig. S5b) , we were not able to detect significant alterations in ProSAP/Shank proteins nor in proteins involved in metal homeostasis. However, given that we could only detect a brain region specific Zn 2? deficiency in mothers, we repeated the same analysis using homogenate from four different brain regions. The results show a trend towards a decrease of ProSAP/Shank proteins especially in hippocampus (Fig. S5c) . Using immunohistochemical read-outs, this trend becomes significant for ProSAP2/Shank3 (Fig. S5d) , with no changes in synapse number (Fig. S5e) .
The loss of ProSAP2/Shank3 has been associated with a decrease in NMDA receptor subunit 1 (GluN1) and AMPA receptor subunit 2 (GluA2) containing protein complexes at the PSD of ProSAP2/Shank3 knockout animals (Bozdagi et al. 2010; Wang et al. 2011; Won et al. 2012) . Therefore, we also quantified the synaptic GluN1 and GluA2 levels in pups. A significant reduction in GluN1 is visible in pups from mothers with Cu 2? overload (Fig. 4a) . To investigate whether the alteration in ProSAP1/ Shank2 in prenatal Cu 2? supplemented animals is caused by a loss of synapses or by an on average weaker scaffold per synapse, we analyzed mean b Fig. 4 Prenatal copper-overload affects ProSAP/Shank proteins: a Western Blot analysis of P2 fractions from whole brain lysate using control pups and pups (PD 3) from Cu 2?
supplemented mice (n = 3). A significant decrease of Pro-SAP1/Shank2, ProSAP2/Shank3, COMMD1, and GluN1 can be seen normalized to Actin. Additionally, an increase in MT-1 levels is visible. Right panel The decrease in ProSAP2/Shank3 comprises all three major isoforms. b-e Sections of three pups from control and three pups from Cu 2? supplemented mice were stained for ProSAP1/Shank2, ProSAP2/Shank3, Shank1 and Bassoon. b The signal intensity of synaptic ProSAP/Shank puncta was evaluated. Although a trend towards a decrease in the mean fluorescence intensity per synapse can be seen in hippocampus, no significant decrease of ProSAP/Shanks could be detected. c Cumulative histograms for hippocampal Pro-SAP1/Shank2 (left) and ProSAP2/Shank3 (right) illustrate that the puncta intensity values are significantly shifted across the highly fluorescent populations of ProSAP1/Shank2 puncta in sections of control pups versus pups from Cu 2? supplemented mice. d Sections of three pups from control and three pups from Cu 2? supplemented mice were stained for ProSAP1/Shank2 and ProSAP2/Shank3. The signal intensity of synaptic puncta for both ProSAP/Shank isoforms was evaluated simultaneously per synapse. A correlation analysis reveals a positive correlation for ProSAP1/Shank2 and ProSAP2/Shank3 signal intensities. Note the shift in slope of the correlation in pups from Cu ProSAP/Shank levels per synapse using immunohistochemistry and quantified the synapse density within brain regions. Apart from a trend in hippocampus, we could not find significant alterations in ProSAP/Shank proteins by averaging fluorescence intensities using brain sections of pups from control and Cu 2? supplemented mice (Fig. 4b) . Importantly, a more detailed analysis of cumulative histograms for hippocampal ProSAP1/Shank2 and ProSAP2/Shank3 signals revealed a significant decrease in ProSAP1/Shank2 levels in the pool of synapses with high ProSAP1/ Shank2 fluorescence (Fig. 4c) . Given that ProSAP1/ Shank2 and ProSAP2/Shank3 fluorescence intensity was found correlated (Fig. 4d) , this pool of synapses might represent mature synapses with strong PSDs. We detected additionally a slight decrease in synapse density in hippocampus of pups from mice on a Cu 2?
enriched diet (Fig. 4e) . This decrease together with the decrease in signal intensity underlines the findings of decreased ProSAP1/Shank2 and ProSAP2/Shank3 levels in the brains of pups from Cu 2? supplemented mice. We conclude that the reduction of ProSAP1/ Shank2 seen by protein biochemistry is based on both, a slight decrease in synapse number and a weaker synaptic scaffold especially in synapses with strong ProSAP1/Shank2 PSD scaffold.
Discussion
The molecular mechanisms that lead to an ASD are not very well understood. However, recent studies point to a strong genetic component of ASD and mutations/ deletion associated with ASD have been found in multiple genes like FMR1, Neurexin1, Neuroligin3 and Neuroligin4 or ProSAP/Shanks. The proteins encoded by these genes can be placed in a common synaptic pathway (Bourgeron 2009; Delorme et al. 2013 ). Nevertheless, it is possible that this pathway is not only influenced by the participating genes themselves, but also by the environment in which the encoded proteins function. Zn 2? deficiency and the dysregulation of biometals were reported in many cases of ASD (Yasuda et al. 2011 (Yasuda et al. , 2013 Jen and Yan 2010) . Moreover, Zn 2? deficiency is associated with the occurrence of seizures (Grabrucker et al. 2011c ) and many patients with ASD suffer from epilepsy. In a recent study, we could show a molecular connection between a deregulation of Zn 2? homeostasis and synaptic malfunction in ASD levels outside of Wilson's disease only during pregnancy (Walker et al. 2011) . In two prior pregnancies, the patient gave birth to a boy, both with elevated copper levels at birth that were both diagnosed with autism later in life. During the course of the third pregnancy, again, Cu 2? levels were as high as 260 lg/ dl (with 70-155 lg/dl considered normal). Along with excess Cu 2? , a Zn 2? deficiency was diagnosed with 61 lg/dl (with 70-150 lg/dl considered as normal) (Walker et al. 2011) . The patient received a Zn 2? supplementation therapy that normalized Zn 2? levels. She delivered a boy, which so far has achieved all appropriate developmental milestones (Walker et al. 2011) and was not diagnosed with autism so far (Walker personal communication) .
In this study, we supplemented excess Cu 2? via the diet of mice. Although we did not find increased Cu 2? levels in the brain, possibly due to protection of the brain by actively controlled uptake of Cu 2? through the blood-brain barrier, we did find increased Cu Pups from Cu 2? supplemented mice showed no signs of increased cell loss due to necrosis, apoptosis or developmental deficits in the brain. However, the molecular composition of their synapses was significantly altered. As before, using prenatal Zn 2? deficient pups from Zn 2? deficient mothers ), we detected a significant reduction in the ASD associated Zn 2? -binding proteins ProSAP1/ Shank2 and ProSAP2/Shank3 along with a possibly compensatory regulation of MT-1 and COMMD1. More important, we also detected alterations in glutamate receptors that have been described previously in ProSAP/Shank knockout animals such as a reduction of GluN1 containing NMDA receptors (Bozdagi et al. 2010; Wang et al. 2011; Won et al. 2012) . A loss of GluN1 similarly has been reported for prenatal Zn 2? deficient animals . The reduction in ProSAP/Shank proteins seen in protein biochemistry read-outs seems to be caused by both, a loss of ProSAP/Shank per synapse with highly ProSAP/Shank expressing, probably mature synapses more affected, and an overall reduction of synapses.
Neurotoxic effects of excess Cu 2? , including fear, nervousness and learning and behavioral disorders (Bjorklund 2013) have been previously described. Interestingly, excess Cu 2? disturbing Zn 2? homeostasis is also weakening the immune system and abnormalities in the immune system have already been described as risk factor for ASD (Grabrucker 2012) . Disturbances in biometal homeostasis can not only be found in ASD but several other neurological disorders. An elevated Cu/Zn ratio for example was also reported in individuals with mood disorders (MD), especially depression, and ADHD (Russo 2011; Pfaender and Grabrucker 2014) . Interestingly, ASD, MD and ADHD share partly similar phenotypes such as increased anxiety and problems in social cognition. Furthermore, ADHD often occurs as comorbidity in ASD. However, the time-point (prenatal vs. postnatal) and duration of exposure to an altered trace metal status might determine its effects. Intriguingly, altered levels of ProSAP2/Shank3 might also be associated with MD and ADHD given that Phelan McDermid Syndrome patients often show signs of ADHD and MD (Denayer et al. 2012) .
Although, increased Cu 2? levels are found in people with Wilson's disease, which is a rather rare disease, the heterozygous form with only one faulty copy of the ATP7B gene is not so rare. Here, the developing fetus of a pregnant woman who is low in Zn 2? and high in Cu 2? may experience major difficulties in the early development of the brain, which may later manifest in ASD (Johnson 2001) . Indeed, manipulation of neurons in vitro by disrupting Zn 2? signaling through the antagonistic effects of Cu 2? leads again to alterations in synaptic ProSAP1/ Shank2 and ProSAP2/Shank3 levels. Additionally, manipulation of the levels of the ASD associated protein COMMD1 (Levy et al. 2011) Taken together, these findings suggest a role of Cu 2? in the pathology of ASD, possibly by causing Zn 2? deficiency, which affects a known ASD associated pathway. Moreover, the results provide further evidence for a link between ASD and a dysfunction of metal ion homeostasis.
Materials and methods

Materials
ZnCl 2 , the Zn 2? chelators CaEDTA and TPEN (N,N,N 0 ,N 0 -tetrakis(2-pyridylmethyl) ethylenediamine), Zinquin ethyl ester and Zinpyr-1 were purchased from Sigma Aldrich. Primary antibodies were purchased from Synaptic Systems (Gephyrin, Homer1, GluN1, GluA2, Bassoon), Novus Biologicals (Shank1 for IF), Santa Cruz (COMMD1, MT3), Sigma Aldrich (COMMD1, Shank1 for WB), Abcam (mGluR5), Acris (MTF1) and Thermo Scientific (MT1). ProSAP1/Shank2 and ProSAP2/Shank3 antibodies have been described previously (Schmeisser et al. 2012) . Secondary Alexa Fluor conjugated antibodies were purchased from Invitrogen. Unless otherwise indicated, all other chemicals were obtained from Sigma Aldrich.
Expression constructs and transfection
The pEGFP (C1-3) vector system (Clontech, Palo Alto, CA, USA) was used for COMMD1 expression constructs and the pSUPER vector system for COMMD1 knockdown. shRNA oligonucleotides were purchased from MWG Eurofins. The target sequence used for COMMD1 knockdown was: GAA GCT GTC AGA GGT GGA A. Hippocampal cells were transfected at day 10 and fixed on 14 DIV using OptiFect (Invitrogen). For a 24 well plate, 5 ll Optifect with 50 ll Neurobasal Medium were incubated for 5 min at RT before mixing with 50 ll Neurobasal Medium and 2 lg DNA per well and incubation for 30 min. Cell lines were transfected using PolyFect (Qiagen) according to the manufacturer's manual.
Immunohistochemistry
Cryosections were thawed for 20 min and fixed in PFA for 20-30 min. After fixation, sections were washed 3 9 10 min with PBS. Sections were permeabilized with 0.2 % Triton in PBS for 2 h and washed again 3 9 10 min with PBS containing 0.05 % Triton. To block non-specific antibody binding, sections were then placed in 10 % FCS in PBS for 2 h. After blocking, sections were incubated with the primary antibody at 37°C for 2 h followed by 3 9 10 min washing with PBS containing 0.05 % Triton. Sections were incubated with the secondary antibody at 37°C for 1.5 h. After washing 3 9 15 min with PBS containing 0.05 % Triton, sections were washed 2 9 5 min with PBS containing DAPI and after a final washing step in H 2 O dest. mounted with Vecta Mount (Vector Laboratories).
TIMM staining was performed as described by Jaarsma and Korf (1990) . In brief, brain sections of 16 lm were cut on a cryostat microtome (-20°C), thaw mounted on glass slides and washed with 0.1 N HCl. After 3 h at RT, sections were placed in a 4 l vacuum dessicator jar containing 100 ml 0.1 % Na 2 S solution, adjusted to pH 7.3 with 2 N HC1, thus forming H 2 S gas. The sections were incubated for 16 h and fixed in 96 % EtOH for 15 min and led through 70 and 50 % EtOH and distilled water, for 2 min each. Subsequently, brain sections were stained in Timm developer (Jaarsma and Korf 1990) at 26°C for 2 h in the dark. Following development, slides were rinsed in H 2 O for 10 min and immersed in 5 % sodium thiosulphate for 10 min. Sections were then rinsed in H 2 O dest., dehydrated through a graded series of EtOH, cleared in xylene and coverslipped after 1-2 h using Entellan Ò (Merck Millipore). Zinpyr1 staining was performed using a final concentration of 10 lM and an incubation time of 1 h at RT.
Nissl staining was performed on cryosections of mouse brains. Sections were incubated with 1 % Cresyl violet in H 2 O (?2 ml 10 % acetic acid) for 5 min, subsequently washed in H 2 O and processed through washing steps with isopropanol (3 9 5 min with 96 % isopropanol, 2 9 5 min with 100 % isopropanol) followed by 2 9 5 min washing with Xylol. Slides were coverslipped with Entellan Ò .
Cell culture, immunocytochemistry and treatments
Hippocampal cultures were prepared from rat (embryonic day 18) as described before (Grabrucker et al. 2009 ). For fluorescent zinc-staining of cultured neurons, growth medium was discarded and the cells were washed three times with HBBS. Coverslips were incubated with a solution of 25 lM Zinquin ethyl ester or 5 lM Zinpyr1 in HBSS for 40 min at 37°C (27). For immunofluorescence, the primary cultures were fixed with 4 % paraformaldehyde (PFA)/4 % sucrose/ PBS at 4°C for 20 min and processed for immunocytochemistry. After washing 3 9 5 min with 19 PBS containing 0.2 % Triton X-100 at RT, blocking was performed with 10 % FBS/1 9 PBS for 1 h at RT, followed by the incubation with primary antibody at RT 2 h or 4°C overnight. After a 3 9 5 min washingstep with 19 PBS, incubation with the secondary antibody coupled to Alexa488, Alexa568 or Alexa647 followed for 1 h. Cell nuclei were counterstained with DAPI and coverslips subsequently mounted using Vecta Mount (Vector Laboratories). For stimulations, growth media were supplemented with 50 mM KCl (HiK ? ), for 1 min. For supplementation ZnCl 2 (10 lM) and CuCl 2 (10 lM) was used.
HEK293 and NIH 3T3 cells were maintained in DMEM at 37°C in 5 % CO 2 .
Protein biochemistry
Membrane-associated fractions from rat brains (P2) were extracted with RIPA buffer at 4°C for 2-3 h by overhead shaking before being centrifuged for 15 min at 13,0009g. Subcellular fractions were isolated as described previously with minor modifications (Schmeisser et al. 2012 ). Proteins were separated by SDS-PAGE and blotted onto Nitrocellulose membranes. Immunoreactivity was visualized using HRP-conjugated secondary antibodies and the SuperSignal detection system (Pierce, Upland, USA).
Measurement of Zn
2? and Cu 2? concentrations
The Zn 2? -and Cu 2? concentration of brain tissue, serum, and feces was measured by inductively coupled plasma mass spectrometry (ICP-MS) at the ''Spurenanalytisches Laboratorium Dr. Baumann'' (Maxhütte-Haidhof, Germany). The zinc-concentration of culture medium and all other organs and blood was measured by AAS at the Department of Clinical Chemistry (ZE klinische Chemie) of the University Hospital Ulm.
Quantitative real-time PCR Isolation of total RNA from 3 control and 3 copper supplemented mice as well as 8 pups from control and copper supplemented mice each was performed using the RNeasy kit (Qiagen) as described by the manufacturer. Isolated RNA was eluted in a total of 40 ll RNase-free water and stored at -80°C. For the reverse transcriptase-mediated PCR studies, first strand synthesis and real-time quantitative RT-PCR amplification were carried out in a one-step, singletube format using the QuantiFast SYBR Green RT-PCR kit. Thermal cycling and fluorescent detection were performed using the Rotor-Gene-Q real-time PCR machine (model 2-Plex HRM) (Qiagen). The qRT-PCR was assayed in 0.1 ml strip tubes in a total volume of 20 ll reaction mixture containing 1 ll of undiluted (normalization: Dilution to the lowest concentration 758.6 ng/ll) total RNA, 2 ll of QuantiTect Primer Assay oligonucleotides, 10 ll of 29 QuantiFast SYBR Green RT-PCR Master Mix supplemented with ROX (5-carboxy-X-rhodamine) dye, 6.8 ll of RNase-free water and 0.2 ll of QuantiFast RT Mix. Amplification conditions were as follows: 10 min at 55°C, 5 min at 95°C, followed by 40 cycles of PCR for 5 s at 95°C for denaturation, 10 s at 60°C for annealing and elongation (one-step). The SYBR Green I reporter dye signal was measured against the internal passive reference dye (ROX) to normalize non-PCR-related fluctuations in. Resulting data were analyzed utilizing the hydroxymethylbilane synthase gene as an internal standard to normalize transcript levels. Cycle threshold (ct) values were calculated by the Rotor-Gene-Q Software (version 2.0.2). All qRT-PCR reactions were run in technical triplicates and mean ct values for each reaction were taken into account for calculations of data analysis. To ascertain primer specificity a melting curve was obtained for the amplicon products to determine their melting temperatures. Real-time quantitative PCR was carried out using oligonucleotides allowing to investigate the expression of MT-1, MT-2. MT-3, MTF1, Shank1, ProSAP1/Shank2 and ProSAP2/Shank3 (validated primer pairs, Quantitect primer assay, Qiagen). Animals 24 female mice (Mus musculus, strain C3H/HenRj) were used for the experiment. 10 weeks old mice were purchased from Janvier and housed in plastic cages under the standard laboratory conditions with average temperature of 22°C and food and water available ad libitum. Lights were automatically turned on/off in a 12 h rhythm (lights on at 7 am). After 1 week of acclimation, mice were divided into two groups, one group of mice (12 females) was fed a copper supplemented diet (30 mg/kg copper, Research Diets Inc.) with tapped water, while the control group (12 females) was fed with standard laboratory food (6 mg/ kg copper) and tapped water. The mice were weighed every day. After 5 weeks, the 3 females of the control and copper supplemented group each were mated. Acute copper supplemented animals were analyzed as well as their offspring that experienced prenatal copper overload and compared to control animals. All animal experiments were performed in compliance with the guidelines for the welfare of experimental animals issued by the Federal Government of Germany and by the local ethics committee (Ulm University) ID Number: 0.103 and 1.132.
Statistics
Synapse measurement
For cell culture experiments ten cells of each condition were imaged. For brain sections, three animals of each group (control, copper supplemented) were used and each of the four brain regions (cerebellum, cortex, hippocampus, striatum) imaged by three optic fields. All signals within the optic fields were quantified in the following way: Fluorescence images were obtained with an upright Axioscope microscope equipped with a Zeiss CCD camera (16 bits; 1280 9 1024 ppi) using Axiovision software (Zeiss) and the strength of the signal intensity analyzed and quantified using ImageJ 1.48r. Statistical analysis was performed using Microsoft Excel for Macintosh and tested for significance using t tests (all values were normally distributed).
Western blot quantification
Evaluation of bands from Western blots (WBs) was performed using ImageJ. At least three animals for each group were used and blots scanned (600 dpi). The individual bands were selected and the integrated density was measured. All WB bands were normalized to ß-actin and the ratios averaged and tested for significance with a level of significance set at 0.05 (p \ 0.05*; \0.01**; \0.001***).
